Skip to main content
SpringerLink
Log in

Fatty acid modulation of tumor cell-platelet-vessel wall interaction

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Summary

Prostaglandins and other eicosanoids have been studied extensively in their physical, biochemical, biophysical and pharmacological aspects. However, studies on their role in tumor progression, especially metastases are relatively recent. Following a brief overview of the history of discovery and metabolism of eicosanoids and other fatty acids, we discuss the functions of these fatty acids (with emphasis on prostacyclin, thromboxane A2, 12-hydroxyeicosatetraenoic acid and 13-hydroxyoctadecadienoic acid) in cell transformation, tumor promotion and particularly in tumor cell metastasis. The relation between these monohydroxy fatty acids and tumor cell metastasis is discussed from three different perspectives, i.e., their effects on tumor cells, on platelets and on endothelial cells. The mechanism of these effects are then addressed at cell adhesion molecule, motility, protease, cell cytoskeleton, protein kinase and eicosanoid receptor levels. Finally, regulation of three key enzymes which generate eicosanoids (phospholipase, prostaglandin endoperoxide synthase and lipoxygenase) is explored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SamuelssonB, GoldyneM, GranstromE, HambergM, HammarstromS, MalmstenC: Prostaglandins and thromboxanes. Ann Rev Biochem 47: 997–1029, 1978

    PubMed  Google Scholar 

  2. NeedlemanP, TurkJ, JakschikBA, MorrisonAR, LefkowithJB: Arachidonic acid metabolism. Ann Rev Biochem 55: 69–102, 1986

    PubMed  Google Scholar 

  3. PiperPJ, SamhounMN: Leukotrienes. Brit Med Bull 43: 297–311, 1987

    PubMed  Google Scholar 

  4. SpectorAA, GordonJA, MooreSA: Hydroxyeicosatetraenoic acids (HETEs). Prog Lipid Res 27: 271–323, 1988

    PubMed  Google Scholar 

  5. PapatheofanisFJ, LandsWEM: Lipoxygenase mechanisms. In: LandsWEM (ed) Biochemistry of arachidonic acid metabolism. Martinus Nijhoff Publishing, Boston, 1985, pp 9–39

    Google Scholar 

  6. DixonRAF, JonesRE, DiehlRE, BennettCD, KargmanS, RouzerCA: Cloning of the cDNA for human 5-lipoxygenase. Proc Natl Acad Sci USA 85: 416–420, 1988

    PubMed  Google Scholar 

  7. BalcarekJM, TheisenTW, CookMN, VarrichioA, HwangS, StrohsackerMW, CrookeST: Isolation and characterization of a cDNA clone encoding rat 5-lipoxygenase. J Biol Chem 263: 13937–13941, 1988

    PubMed  Google Scholar 

  8. FunkCD, FurciL, FitzgeraldGA: Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Proc Natl Acad Sci USA 87: 5638–5642, 1990

    PubMed  Google Scholar 

  9. YoshimotoT, SuzukiH, YamamotoS, TakaiT, YokoyamaC, TanabeT: Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. Proc Natl Acad Sci USA 87: 2142–2146, 1990

    PubMed  Google Scholar 

  10. DeMarzoN, SloaneDL, DicharryS, HighlandE, SigalE: Cloning and expression of an airway epithelial 12-lipoxygenase. Am J Physiol 262: L198-L207, 1992

    PubMed  Google Scholar 

  11. SigalE, CraikCS, HighlandE, GrunbergerD, CostelloLL, DixonRAF, NadelJA: Molecular cloning and primary structure of human 15-lipoxygenase. Biochem Biophys Res Commun 157: 457–464, 1988

    PubMed  Google Scholar 

  12. O'PreyJ, ChesterJ, ThieleBJ, JanetzkiS, PrehnS, FlemingJ, HarrisonPR: Promoter structure and complete sequence of the gene encoding the rabbit erythroid cell-specific 15-lipoxygenase. Gene 84: 493–499, 1989

    PubMed  Google Scholar 

  13. YokoyamaC, TanabeT: Cloning of human encoding prostaglandin endoperide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 165: 888–894, 1989

    PubMed  Google Scholar 

  14. DeWittAL, El-HarithEA, KraemerSA, AndrewsMJ, YaoEF, ArmstrongRL, SmithWL: The aspirin and heme-binding site of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 265: 5192–5198, 1990

    PubMed  Google Scholar 

  15. DeWittDL, SmithWL: Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 85: 1412–1416, 1988

    PubMed  Google Scholar 

  16. FunkCD, HoshikoS, MatsumotoT, RadmarkO, SamuelssonB: Characterization of the human 5-lipoxygenase gene. Proc Natl Acad Sci USA 86: 2587–2591, 1989

    PubMed  Google Scholar 

  17. KraemerSA, MeadeEA, DeWittDL: Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5′-flanking regulatory sequences. Arch Biochem Biophys 293: 391–400, 1992

    PubMed  Google Scholar 

  18. HammarstromS: Biosynthesis and biological actions of prostaglandins and thromboxanes. Arch Biochem Biophys 214: 431–445, 1982

    PubMed  Google Scholar 

  19. HammarstromS: Prostaglandin production by normal and transformed 3T3 fibroblasts in cell culture. Eur J Biochem 74: 7–12, 1977

    PubMed  Google Scholar 

  20. RitziEM, StylosWA: Prostaglandin production in cultures of Balb/3T3 and SV3T3 mouse fibroblasts. J Natl Cancer Inst 56: 529–533, 1976

    PubMed  Google Scholar 

  21. BarkerK, AderemA, HanafusaH: Modulation of arachidonic acid metabolism by Rous sarcoma virus. J Virol 63: 2929–2935, 1989

    PubMed  Google Scholar 

  22. AlonsoT, MorganRO, MarvizonJC, ZarblH, SantosE: Malignant transformation by ras and other oncogene produces common alterations in inositol phospholipid signaling pathways. Proc Natl Acad Sci USA 85: 4271–4275, 1988

    PubMed  Google Scholar 

  23. HanJ, SadowskiH, YoungDA, MacaraIG: Persistent induction of cyclooxygenase in p60v-src transformed 3T3 fibroblasts. Proc Natl Acad Sci USA 87: 3373–3377, 1990

    PubMed  Google Scholar 

  24. XieW, ChipmanJG, RobertsonDL, EriksonRL, SimmonsDL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692–2696, 1991

    PubMed  Google Scholar 

  25. KarimSMM, RaoB: Prostaglandins and tumors. In: KarimSMM (ed) Prostaglandins: Physiological, pharmacological and pathological aspects. Univ Park Press, Baltimore, 1976, pp 303–325

    Google Scholar 

  26. Levine L: Arachidonic acid transformation and tumor production. In: Lein G, Weinmhouse S (eds) Advances in cancer research. Academic Press, 1981, 35: 49–79

  27. Levine L: Tumor promoters and prostaglandin production. In: Nigam SK, McBrien DCH, Slater TF (eds) Eicosanoids, lipid peroxidation and cancer. Springer-Verlag, 1988, pp 11–21

  28. Ullrich V, Hecker M, Nusing R, Rosenbach T: Thromboxane A2 and prostacyclin in tumorigenesis. In: Nigam SK, McBrien DCH, Slater TF (eds) Eicosanoids, lipid peroxidation and cancer. Springer-Verlag, 1988, pp 4–10

  29. WuKK, HatzakisH, LoSS, SeongDC, SandujaSK, TaiHH: Stimulation ofde novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J Biol Chem 263: 19043–19047, 1988

    PubMed  Google Scholar 

  30. OhuchiK, LevineL: Stimulation of prostaglandin synthesis by tumor-promoting phorbol-12,13-diesters in canine kidney (MDCK) cells. J Biol Chem 253: 4783–4790, 1978

    PubMed  Google Scholar 

  31. ZenserTV, ElingTE, DuniecZM, HuangYH, DavisBB: Mechanism of 12-O-tetradecanoylphorbol-13-acetate enhanced metabolism of arachidonic acid in dog urothelial cells. Cancer Res 50: 4650–4655, 1990

    PubMed  Google Scholar 

  32. DuniecZM, NettesheimP, ElingTE: Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C. Mol Pharmacol 39: 164–170, 1990

    Google Scholar 

  33. ParkerJ, DanielLW, WaiteM: Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis. J Biol Chem 262: 5385–5393, 1987

    PubMed  Google Scholar 

  34. HabenichtAJR, GoerigM, GrulichJ, RotheD, GronwaldR, LothU, SchettierG, KommerellB, RossR: Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapidde novo synthesis of cyclooxygenase. J Clin Invest 75: 1381–1387, 1985

    PubMed  Google Scholar 

  35. LinAH, BienkowskiMJ, GormanRR: Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor. J Biol Chem 264: 17379–17383, 1989

    PubMed  Google Scholar 

  36. YokotaK, KusakaM, OhshimaT, YamamotoS, KuriharaN, YoshinoT, KumegawaM: Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T#-E1) by epidermal growth factor. J Biol Chem 261: 15410–15415, 1986

    PubMed  Google Scholar 

  37. CaseyML, KorteK, MacDonaldPC: Epidermal growth factor stimulation of prostaglandin E2 biosynthesis in amnion cells, induction of prostaglandin H2 synthase. J Biol Chem 263: 7846–7854, 1988

    PubMed  Google Scholar 

  38. TopleyN, FloegeJ, WesselK, HassR, RadekeHH, KaeverV, ReschK: Prostaglandin E2 production is synergistically increased in cultured human glomerular mesangial cells by combinations of IL-1 and tumor necrosis factor-α. J Immunol 143: 1989–1995, 1989

    PubMed  Google Scholar 

  39. RazA, WycheA, SiegelN, NeedlemanP: Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem 263: 3022–3028, 1988

    PubMed  Google Scholar 

  40. MaierJAM, HlaT, MaciagT: Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 265: 10805–10808, 1990

    PubMed  Google Scholar 

  41. KusakaM, OshimaT, YokotaK, YamamotoS, KumegawaM: Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP. Biochim Biophys Acta 972: 339–346, 1988

    PubMed  Google Scholar 

  42. HartIR, GoodeNT, WilsonRE: Molecular aspects of the metastatic cascade. Biochim Biophys Acta 989: 65–84, 1989

    PubMed  Google Scholar 

  43. WeissL, OrrFW, HonnKV: Interactions of cancer cells with the microvasculature during metastasis. FASEB J 2: 12–21, 1988

    PubMed  Google Scholar 

  44. Honn KV, Menter DG, Steinert BW, Taylor JD, Onoda JM, Sloane BF: Analysis of platelet, tumor cell and endothelial cell interactionsin vivo andin vitro. In: Garaci E, Paoletti R, Santoro MG (eds) Prostaglandins in cancer research. Springer-Verlag, 1987, pp 172–183

  45. CrissmanJD, HatfieldJS, MenterDG, SloaneBF, HonnKV: Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res 48: 4065–4072, 1988

    PubMed  Google Scholar 

  46. KawaguchiT, NakamuraK: Cancer Metastasis Rev 5: 77–94, 1986

    PubMed  Google Scholar 

  47. MenterDG, HatfieldJS, HarkinsCJ, SloaneBF, TaylorJD, CrissmanJD, HonnKV: Tumor cell-platelet interactionsin vitro and their relationship toin vivo arrest of hematogenously circulating tumor cells. Clin Expl Metastasis 5: 65–78, 1987

    Google Scholar 

  48. MoncadaS, HiggsEA: Arachidonate metabolism in blood cells and the vessel wall. Clin Haemato 15: 273–292, 1986

    Google Scholar 

  49. BuchananMR, HaasTA: 13-hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem 260: 16056–16059, 1985

    PubMed  Google Scholar 

  50. PiperPJ, LettsLG, GaltonSA: Generation of a leukotriene-like substance from porcine vascular and other tissues. Prostaglandins 25: 591–599, 1983

    PubMed  Google Scholar 

  51. HonnKV, CiconeB, SkoffA: Prostacyclin, a potent antimetastatic agent. Science 212: 1270–1272, 1982

    Google Scholar 

  52. SloaneBF, MakimS, DunnJR, LacosteR, TheodorouM, BattistaJ, AlexR, HonnKV: Lipoxygenase products as mediators of tumor cell lysosomal enzyme release: Inhibition by nafazatrom. Prostaglandins and cancer: First international conference, Alan R. Liss New York, NY10011, 1982, pp 789–792

    Google Scholar 

  53. HonnKV, BussWD, SloaneBF: Prostacyclin and thromboxanes: Implications for their role in tumor cell metastasis. Biochem Pharmacol 32: 1–11, 1983

    PubMed  Google Scholar 

  54. MenterD, NeagosG, DunnJ, PalazzoR, TchenTT, TaylorJD, HonnKV: Tumor cell induced platelet aggregation: Inhibition by prostacyclin, thromboxane A2 and phosphodiesterase inhibitors. Prostaglandins and cancer: First international conference, Alan R. Liss New York, NY10011, 1982, pp 809–813

    Google Scholar 

  55. HonnKV, DunnJR: Nafazatrom inhibition of tumor cell lipoxygenase activity and cellular proliferation. FEBS Lett 139: 65–68, 1982

    PubMed  Google Scholar 

  56. MarnettLJ, SiedlikPH, OchsRC, PagelsWR, DasM, HonnKV, WarnockRH, TainerBE, ElingTE: Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Mol Pharmacol 26: 328–335, 1984

    PubMed  Google Scholar 

  57. Honn KV, Chen YQ: Prostacyclin, hydroxy fatty acids and tumor metastasis. In: Rubanyi GM, Vane JR (eds) Prostacyclin: New perspectives in basic research and novel therapeutic indications. Elsevier Science Publishers, Amsterdam, The Netherlands, in press

  58. HonnKV, GrossiIM, TimarJ, ChopraH, TaylorJD: Platelets and cancer metastasis. In: OrrFW, BuchananM, WeissL (eds) CRC Press, Inc., Boca Raton, FL, 1991, pp 93–110

    Google Scholar 

  59. ChopraH, TimarJ, RongX, GrossiIM, HatfieldJS, FligielSEG, FinchCA, TaylorJD, HonnKV: Is there a role for the tumor cell integrin αIIbβ3 and cytoskeleton in tumor cell-platelet interaction. Clin Expl Metastasis 10: 125–138, 1992

    Google Scholar 

  60. Steinert BW, Tang DG, Jones CL, Grossi IM, Umbarger LA, Honn KV: Studies on the role of platelet eicosanoid metabolism and integrin αIIbβ3 in tumor cell induced platelet aggregation, submitted

  61. Honn KV, Nelson KK, Renaud C, Bazaz R, Diglio CA, Timar J.: Fatty acid modulation of tumor cell adhesion to microvessel endothelium and experimental metastasis. Prostaglandins (in press)

  62. GrossiIM, FitzgeraldLA, UmbargerLA, NelsonKK, DioglioCA, TaylorJD, HonnKV: Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res 49: 1029–1037, 1989

    PubMed  Google Scholar 

  63. HonnKV, GrossiIM, DiglioCA, WojtukiewiczM, TaylorJD: Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)-HETE-induced endothelial cell retraction. FASEB J 3: 2285–2293, 1989

    PubMed  Google Scholar 

  64. Timar J, Chen YQ, Liu B, Bazaz R, Taylor JD, Honn KV: The lipoxygenase metabolite 12(S)-HETE promotes αIIbβ3 integrin mediated tumor cell spreading on fibronectin, Int J Cancer, in press

  65. Tang D, Diglio CA, Honn KV: 12(S)-HETE-induced microvascular endothelial cell retraction is mediated by cytoskeletal rearrangement dependent on PKC activation. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 219–229

  66. HonnKV, SteinertBW, MoinK, OnodaJM, TaylorJD, SloaneBF: The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation. Biochem Biophys Res Commun 29: 384–389, 1987

    Google Scholar 

  67. Grossi IM, Diglio CA, Honn KV: Control of tumor cell induced endothelial cell retraction by lipoxygenase metabolites, prostacyclin and prostacyclin analogues. In: Honn KV, Marnett LJ, Nigam S, Walden T (eds) Eicosanoids and other bioactive lipids in cancer and radiation injury. Kluwer Academic Publishers, 1991, pp 409–414

  68. Marnett LJ, Leithauser MT, Richards KM, Blair I, Honn KV, Yamamoto S, Yoshimoto T: Arachidonic acid metabolism of cytosolic fractions of Lewis lung carcinoma cells. In: Samuelson B, Paoletti R, Ramwell P (eds) Adv Prostacyclin Thromboxane Leukotriene Res. Raven Press, 1991, 21: 895–900

  69. Buchanan MR, Bertomeu MC, Bastida E, Orr FW, Gallo S: Eicosanoid metabolism and tumor cell endothelial cell adhesion. In: Honn KV, Marnett LJ, Nigam S, Walden T (eds) Eicosanoids and other bioactive lipids in cancer and radiation injury. Kluwer Academic Publishers, 1991, pp 347–350

  70. Buchanan MR, Bertomeu MC, Gallo S, Orr FW: Fatty acid regulation of endothelial cell adhesion molecules and tumor cell adhesion: Implications in metastasis. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 619–622

  71. Honn KV, Tang DG, Chen YQ: Platelets and cancer metastasis: More than an epiphenomenon. Sem Throm Hemost 18: 390–413

  72. Fitzgerald LA, Phillips DR: Platelet membrane glycoproteins. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and Thrombosis: Basic Principles and Clinical Practice.2nd ed, JB Lippincott, 1988, pp 572–593

  73. PhillipsDR, CharoIF, ScarboroughRM: GpIIb-IIIIa: the responsive integrin. Cell 65: 359–362, 1991

    PubMed  Google Scholar 

  74. GrossiIM, HatfieldJS, FitzgeraldLA, NewcombeM, TaylorJD, HonnKV: Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J 2: 2385–2395, 1988

    PubMed  Google Scholar 

  75. ChangYS, ChengYQ, FitzgeraldLA, HonnKV: Analysis of integrin mRNA in human and rodent tumor cells. Biochem Biophys Res Commun 176: 108–113, 1991

    PubMed  Google Scholar 

  76. Chen YQ, Gao X, Timar J, Tang D, Grossi IM, Chelladurai M, Kunicki TJ, Fligiel SEG, Taylor JD, Honn KV: Identification on the αIIbβ3 integrin in murine tumor cells. J Biol Chem, in press

  77. Chen YQ, Gao X, Honn KV: Wide distribution of αIIb integrin among tumor cells: its potential importance. Submitted

  78. ChopraH, TimarJ, ChenYQ, RongX, GrossiIM, FitzgeraldLA, TaylorJD, HonnKV: The lipoxygenase metabolite 12(S)-HETE induces cytoskeleton-dependent increase in surface expression of integrin αIIbβ3 on melanoma cells. Int J Cancer 49: 774–786, 1991

    PubMed  Google Scholar 

  79. HonnKV, ChenYQ, TimarJ, OnodaJM, HatfieldJS, FligielSEG, SteinertBW, DiglioCA, GrossiIM, NelsonKK, TaylorJD: αIIbβ3 integrin expression and function in subpopulations of murine tumors. Exp Cell Res 201: 23–32, 1992

    PubMed  Google Scholar 

  80. ChangYS, ChenYQ, TimarJ, NelsonKK, GrossiIM, FitzgeraldLA, DiglioCA, HonnKV: Increased expression of αIIbβ3 integrin in lung-colonizing subpopulations of murine melanoma cells. Int J Cancer 51: 445–451, 1992

    PubMed  Google Scholar 

  81. Grossi IM, Honn KV: PG12 and its analogs inhibit 12-HETE induced expression of the αIIbβ3 integrin and adhesion in W256 carcinosarcoma cells. Submitted

  82. Liu B, Renaud C, Nelson KK, Chen YQ, Bazaz R, Kowynia J, Timar J, Diglio CA, Honn KV: Protein kinase C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer 52: 147–152

  83. Tang DG, Chen YQ, Renaud C, Diglio CA, Honn KV: PKC-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor. Submitted

  84. Raz A, Silletti S, Timar J, Honn KV: Effect of 12-HETE on the expression of autocrine motility factor receptor and motility in melanoma cells. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 645–649

  85. Sloane BF, Rozhin J, Gomez AP, Grossi IM, Honn KV: Effects of 12-hydroxyeicosatetraenoic acid on release of cathepsin B and cysteine proteinase inhibitors from malignant melanoma cells. In: Honn KV, Marnett LJ, Nigam S, Walden T (eds) Eicosanoids and other bioactive lipids in cancer and radiation injury. Kluwer Academic Publishers, 1991, pp 373–377

  86. Taylor JD, Timar J, Tang D, Bazaz R, Chopra H, Kimler V, Honn KV: 12(S)-HETE induces cytoskeleton phosphorylations and rearrangement in melanoma cells. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 635–638

  87. Liu B, Hannun YA, Khan WA, Renaud C, Wetsel WC, Honn KV: Alteration of membrane association of protein kinase Cα in B16 amelanotic melanoma cells by arachidonate and linoleate derived monohydroxy fatty acids. Submitted

  88. Tang DG, Timar J, Grossi IM, Renaud C, Kimler VA, Diglio CA, Taylor JD, Honn KV: The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Submitted

  89. Liu B, Marnett LJ, Blair I, Nelson KK, Renaud C, Diglio CA, Honn KV: Correlation of 12(S)-HETE and 13(S)-HODE biosynthesis to the metastatic potential of tumor cells. Submitted

  90. SmithWL: The eicosanoids and their biochemical mechanisms of action. Biochem J 259: 315–324, 1989

    PubMed  Google Scholar 

  91. SamuelssonB, GranstromE, GreenK, HambergM, HammarstromS: Prostaglandins. Ann Rev Biochem 44: 669–695, 1975

    PubMed  Google Scholar 

  92. NicosiaS, PatronoC: Eicosanoid biosynthesis and action: novel opportunities for pharmacological intervention. FASEB J 3: 1941–1948, 1989

    PubMed  Google Scholar 

  93. Gardiner PJ: Classification of prostanoid receptors. In: Samuelsson B, Dahlen S, Fritsch J, Hedqvist P (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, 1990, 20: 110–118

  94. SamuelssonB, RamwellPW, PaolettiR, FolcoG, GranstromE: Advances in prostaglandin, thromboxane and leukotriene research 21A: 331–414, 1991

    Google Scholar 

  95. GorsiniA, FolcoGG, FumagalliR, NicosiaS, NoeMA, OlivaD: (5Z)-carbacyclin discriminates between prostacyclin receptors coupled to adenylate cyclase in vascular smooth muscle and platelets. Br J Pharmacol 90: 255–261, 1987

    PubMed  Google Scholar 

  96. MasudaA, MaisDE, OatisJE, HalushkaPV: Platelet and vascular thromboxane A2/prostaglandin H2 receptors—Evidence for different subclasses in the rat. Biochem Pharmacol 42: 537–544, 1991

    PubMed  Google Scholar 

  97. GrossE, RuzickaT, MauchC, KriegT: Evidence for LTB4/12-HETE binding sites in a human epidermal cell line. Prostaglandins 36: 49–58, 1988

    PubMed  Google Scholar 

  98. GrossE, RuzickaT, RestorffB, StolzW, KlotzK: Highaffinity binding and lack of growth-promoting activity of 12(S)-HETE in a human epidermal cell line. J Invest Dermatol 94: 446–451, 1990

    PubMed  Google Scholar 

  99. SussR, ArenbergerP, GrossE, RuzickT: Regulation of 12(S)-HETE binding sites on human epidermal cells by interferon-γ. Exp Cell Res 191: 204–208, 1990

    PubMed  Google Scholar 

  100. SmrckaAV, HelperJR, BrownKO, SternweisPC: Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251: 804–807, 1991

    PubMed  Google Scholar 

  101. Rouzer CA: Regulation and structure of human leukocyte 5-lipoxygenase. In: Crook ST, Wong A (eds) Lipoxygenases and their products. Academic Press, 1991, pp 51–65

  102. Wong A: Regulation of 5-lipoxygenase activity in rat basophilic leukemia cells. In: Crook ST, Wong A (eds) Lipoxygenases and their products. Academic Press, 1991, pp 67–87

  103. Kramer RM, Johansen B, Hession C, Pepinsky RB: Characterization of a secretable phospholipase A2 from human platelets. In: Samuelsson B, Dahlen S, Fritsch J, Hedqvist P (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, 1990, 20: 79–86

  104. HeinriksonRL, KruegerET, KeimPS: Amino acid sequence of phospholipase A2-α from venom of crotalus adamanteus, a new classification of phospholipases A2 based upon structural determinants. J Biol Chem 252: 4913–4921, 1977

    PubMed  Google Scholar 

  105. Lapetina EG, Crouch MF: Relationship of inositol phospholipid metabolism to phospholipase A2. In: Samuelsson B, Wong PYK, Sun FF (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, 1989, 19: 568–573

  106. ClarkMA, OzgurLE, ConwayTM, DispotoJ, CrookST, BomalaskiJS: Cloning of a phospholipase A2-activating protein. Proc Natl Acad Sci USA 88: 5418–5422, 1991

    PubMed  Google Scholar 

  107. PashJM, BaileyJM: Inhibition by corticosteroids of epidermal growth factor-induced recovery of cyclooxygenase after aspirin inactivation. FASEB J 2: 2613–2618, 1988

    PubMed  Google Scholar 

  108. Chang WC, Ning CC, Lin MT, Huang JD: Epidermal growth factor enhances a microsomal 12-lipoxygenase activity in A431 cells. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 463–466

  109. Glasgow WC, Eling TE: Epidermal growth factor regulation of linoleic acid metabolism in syrian hamster embryo fibroblasts. In: Nigam S, Honn KV, Marnett LJ, Walden T (eds) Eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury. Kluwer Academic Publishers, 1992, pp 467–470

  110. Wong A, Hwang SM, Cook MN: The regulation of 5-lipoxygenase activity in rat basophilic leukemia cells. In: Samuelsson B, Dahlen S, Fritsch J, Hedqvist P (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven Press, 1990, 20: 28–34

  111. FunkCD, FitzgeraldGA: Eicosanoid forming enzyme mRNA in human tissues. J Biol Chem 266: 12508–12513, 1991

    PubMed  Google Scholar 

  112. MillerDK, GillardJW, VickersPJ, SadowskiS, LeveilleC, ManciniJA, CharlesonP, DixonRAF, Ford-HutchinsonAW, FortinR, GauthierJY, RodkeyJ, RosenR, RouzerC, SigalIS, StraderCD, EvansJF: Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343: 278–281, 1990

    PubMed  Google Scholar 

  113. DixonRAF, DiehlRE, OpasE, RandsE, VickersPJ, EvansJF, GillardJW, MillerDK: Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343: 282–284, 1990

    PubMed  Google Scholar 

  114. ReidGK, KargmanS, VickersPJ, MancinJA, LeveilleC, EthierD, MillerDK, GillardJW, DixonRAF, EvansJF: Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265: 19818–19823, 1990

    PubMed  Google Scholar 

  115. AgarwallKC, ParksREJr: Foskolin: a potential anti-metastatic agent. Int J Cancer 32: 801–804, 1983

    PubMed  Google Scholar 

  116. HonnKV: Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin Expl Metastasis 1: 103–114, 1983

    Google Scholar 

  117. TanakaK, FukumotoS: Cancer blood-borne metastasis and platelets. Jpn J Cancer Chemother 11: 2453–2459, 1984

    Google Scholar 

  118. KarpatkinS, AmbrogioC, PearlsteinE: Lack of effect ofin vivo prostacyclin on the development of pulmonary metastases in mice following intravenous injection of CT 26 colon carcinoma, Lewis lung carcinoma, or B16a amelanotic melanoma cells. Cancer Res 44: 3880–3883, 1984

    PubMed  Google Scholar 

  119. GorelikE, BereWW, HerbermanRB: Role of NK cells in the metastatic effect of anticoagulant drugs. Int J Cancer 33: 87–94, 1984

    PubMed  Google Scholar 

  120. JeneyA, LapisK, KopperL, PalK, TimarF, InstitorisL, GalambosG: Tumor progression and prostaglandins. In: MuszbekL (ed) Hemostasis and Cancer. CRC Press, Inc., Boca Raton, FL, 1987, pp 207–214

    Google Scholar 

  121. MahalingamM, UgenKE, KaoKJ, KleinPA: Functional role platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants. Cancer Res 48: 1460–1464, 1988

    PubMed  Google Scholar 

  122. CostantiniV, FuschiottiP, AllegrucciA, NencilGG, FiorettiMC: Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formation. Cancer Chemother Pharmacol 22: 289–293, 1988

    PubMed  Google Scholar 

  123. NiitsuY, IshigakiS, KogawaK, MogiY, WatanabeN, KohgoY, UrushizakiI: Effect of combined administration of a prostacyclin analogue and adriamycin against the artificial metastasis of Meth A cell. Invasion Metastasis 8: 57–72, 1988

    PubMed  Google Scholar 

  124. SavaG, PerissinL, ZorzetS, PicciniP, GiraldiT: Anti-metastatic action of the prostacyclin analog iloprost in the mouse. Clin Expl Metastasis 7: 671–678, 1989

    Google Scholar 

  125. KatoS, KobariM, MatsunoS, SatoT: Inhibitory effect of anti-platelet prostaglandin on liver metastasis of hamster pancreatic cancer. J Jpn Surg Society 90: 745–752, 1989

    Google Scholar 

  126. TzanakakisGN, AgarwallKC, VezeridisMP: Inhibition of hepatic metastasis from a human pancreatic adenocarcinoma (RWP-2) in the nude mouse by prostacyclin, forskolin, and ketoconazole. Cancer 65: 446–451, 1990

    PubMed  Google Scholar 

  127. LapisK, TimarJ, PapayJ, PakuS, SzendeB, LadanyiA: Experimental metastasis inhibition by pretreatment of the host. Arch Geschwulstforsch 60: 97–102, 1990

    PubMed  Google Scholar 

  128. ConstantiniV, GiampietriA, AllegrucciM, AgnelliG, NenciGG, FiorettiMC: Mechanisms of the antimetastatic activity of stable prostacyclin analogues: modulation of host immunocompetence. Adv Prostaglandin Thromboxane Leukotriene Res 21: 917–920, 1990

    Google Scholar 

  129. SchneiderMR, SchillingerE, SchirnerM, SkuballaW, SturzebeckerS, WittW: Effects of prostacyclin analogues inin vivo tumor models. Adv Prostaglandin Thromboxane Leukotriene Res 21: 901–908, 1990

    Google Scholar 

  130. GiraldiT, RapozziV, PerissinL, ZorzetS: Antimetastatic action of stable prostacyclin analogs in mice. Adv Prostaglandin Thromboxane Leukotriene Res 21: 913–916, 1990

    Google Scholar 

  131. SchirnerM, SchneiderMR: Cicaprost inhibits metastasis of animal tumors. Prostaglandins 42: 451–461, 1991

    PubMed  Google Scholar 

  132. SchneiderMR, SchirnerM: Demonstration of antimetastatic effects of prostacyclin analoguesin vivo. In: NigamS, HonnKV, MarnettLJ, WaldenT (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Kluwer Academic Publishers, Boston, 1992, pp 657–662

    Google Scholar 

  133. HonnKV, MeyerJ: Thromboxane and prostacyclin: Positive and negative modulators of tumor growth. Biochem Biophys Res Commun 102: 1122–1129, 1981

    PubMed  Google Scholar 

  134. HonnKV, SloaneBF: Prostacyclin, thromboxanes, and hematogenous metastasis. Adv Prostaglandin Thromboxane Leukotriene Res 12: 313–319, 1983

    Google Scholar 

  135. HonnKV, OnodaJM, MenterDG, TaylorJD, SloaneBF: Prostacyclin in the control of tumor metastasis. In: CohenMM (ed) Biologic Protection With Prostaglandins. CRC Press, Inc., Boca Raton, FL, 1985, pp 92–110

    Google Scholar 

  136. Honn KV, Onoda JM, Menter DG, Cavanaugh PG, Taylor JD, Crissman JD, Ryan RE, Sloane BF: Possible strategies for antimetastatic therapy. In: Welch DR, Bhuyan BK, Liotta L (eds) Cancer Metastasis: Experimental and Clinical Strategies. Alan R. Liss, Inc., 1986, pp 217–246

  137. MenterDG, SteinertBW, SloaneBF, TaylorJD, HonnKV: A newin vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Cancer Res 47: 2425–2432, 1987

    PubMed  Google Scholar 

  138. VergoteIB, vanDamPA, LaekemanGM, KeersemaeckersGH, UyttenbroeckFL, HermanAG: Prostacyclin/thromboxane ratio in human breast cancer. Tumour Biol 12: 261–266, 1991

    PubMed  Google Scholar 

  139. StolmanGJ: Plasma thromboxane A2 and prostacyclin concentrations in squamous cell carcinoma of the head and neck. J Surg Oncol 38: 33–37, 1988

    PubMed  Google Scholar 

  140. Aitokallio-TallbergAM, JungJK, KimSJ, ViinikkaLU, YlikorkalaRO: Urinary excretion of degradation products of prostacyclin and thromboxanes is increased in patients with gestational choriocarcinoma. Cancer Res 51: 4146–4148, 1991

    PubMed  Google Scholar 

  141. MehtaP, LawsonD, WardMB, Lee-AmbroseL, KimuraA: Effects on thromoxane A2 inhibition on osteogenic sarcoma cell-induced platelet aggregation. Cancer Res 46: 5061–5063, 1986

    PubMed  Google Scholar 

  142. RadomskyMW, JenkinsDC, HolmesL, MoncadaS: Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res 51: 6073–6078, 1991

    PubMed  Google Scholar 

  143. TohgoA, TanakaNG, OsadaY: Inhibitory effects of DN-9693 on platelet-enhanced tumor cell attachment to cultured endothelium. Invasion Metastasis 10: 1–17, 1990

    PubMed  Google Scholar 

  144. MenterDG, OnodaJM, TaylorJD, HonnKV: Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res 44: 450–456, 1984

    PubMed  Google Scholar 

  145. MenterDG, OnodaJM, MoilanenD, SloaneBF, TaylorJD, HonnKV: Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. JNCI 78: 961–969, 1987

    PubMed  Google Scholar 

  146. HonnKV, DunnJR: Nafazatrom (Bay g6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation. FEBS Lett 139: 65–68, 1982

    PubMed  Google Scholar 

  147. OnodaJM, SloaneBF, HonnKV: Antithrombogenic effects of calcium channel blockers: Synergism with prostacyclin and thromboxane synthase inhibitors. Thromb Res 34: 367–378, 1984

    PubMed  Google Scholar 

  148. LambNJC, FernandezA, FeramiscoJR, WelchWJ: Modulation of vimentin containing intermediate filament distribution and phosphorylation in living fibroblasts by the cAMP-dependent protein kinase. J Cell Biol 108: 2409–2422, 1989

    PubMed  Google Scholar 

  149. vanWilligenG, AkkermanJ-WN: Protein kinase C and cyclic AMP regulated reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets. Biochem J 273: 115–120, 1991

    PubMed  Google Scholar 

  150. LiuB, TimarJ, HowlettJ, DiglioCA, HonnKV: Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regulation 2: 1045–1055, 1991

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Wayne State University, 48202, Detroit, MI, USA

    Yong Q. Chen, Bin Liu, Dean G. Tang & Kenneth V. Honn

  2. Department of Chemistry, Wayne State University, 48202, Detroit, MI, USA

    Yong Q. Chen, Bin Liu, Dean G. Tang & Kenneth V. Honn

Authors
  1. Yong Q. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bin Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dean G. Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenneth V. Honn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, Y.Q., Liu, B., Tang, D.G. et al. Fatty acid modulation of tumor cell-platelet-vessel wall interaction. Cancer Metast Rev 11, 389–409 (1992). https://doi.org/10.1007/BF01307189

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01307189

Key words

Search

Navigation